Boston Micro Fabrication Launches BMF Biotechnology Inc. to Advance Use of 3D BioChips in Pharmaceutical and Cosmetic Research
To better support the use of highly precise, microfluidic solutions in advanced drug development, pharmaceutical and cosmetic research, Boston Micro Fabrication (BMF) proudly introduces BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. is dedicated to developing and commercializing innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale tissues in vitro, helping accelerate new drug and cosmetic development.
- To better support the use of highly precise, microfluidic solutions in advanced drug development, pharmaceutical and cosmetic research, Boston Micro Fabrication (BMF) proudly introduces BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. is dedicated to developing and commercializing innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale tissues in vitro, helping accelerate new drug and cosmetic development.
- Starting in late 2022, BMF began to expand the business beyond supplying the Projection Micro Stereolithography (PµSL) platform and associated parts delivery.
- As part of this initiative, BMF inaugurated the San Diego Research Institute, dedicated to advancing innovative microfluidic BioChips for drug discovery and cosmetic testing.
- To help fully realize the power of the BioChips, BMF Biotechnology is now recruiting collaboration Partners.